A new multinational cohort study reports that patients receiving daily haemodialysis had a significantly higher mortality rate than those receiving conventional thrice-weekly treatments. Other studies have suggested that daily haemodialysis has beneficial effects. What are patients and nephrologists to make of these conflicting findings?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Suri, R. S. et al. A multinational cohort study of in-center daily hemodialysis and patient survival. Kidney Int. http://dx.doi.org/10.1038/ki.2012.329.
Eknoyan, G. et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N. Engl. J. Med. 347, 2010–2019 (2002).
Foley, R. N., Gilbertson, D. T., Murray, T. & Collins, A. J. Long interdialytic interval and mortality among patients receiving hemodialysis. N. Engl. J. Med. 365, 1099–1107 (2011).
Suri, R. S. et al. Daily hemodialysis: a systematic review. Clin. J. Am. Soc. Nephrol. 1, 33–42 (2006).
Kjellstrand, C. M. et al. Short daily haemodialysis survival in 415 patients treated for 1006 patient-years. Nephrol. Dial. Transplant. 23, 3283–3289 (2008).
Blagg, C. R., Kjellstrand, C. M., Ting, G. O. & Young, B. A. Comparison of survival between short-daily hemodialysis and conventional hemodialysis using the standardized mortality ratio. Hemodialysis Int. 10, 37–374 (2006).
Suri, R. S. et al. Frequent Hemodialysis Network (FHN) randomized trials: study design. Kidney Int. 71, 349–359 (2007).
FHN Trial Group. In-center hemodialysis six times per week versus three times per week. N. Engl. J. Med. 363, 2287–2300 (2010).
Zoccali, C. et al. Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int. 65, 1492–1498 (2004).
Kliger, A. S. High frequency hemodialysis: rationale for randomized clinical trial. Clin. J. Am. Soc. Nephrol. 2, 390–392 (2007).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
A. Kliger serves on the Scientific Advisory Board for NxStage.
Rights and permissions
About this article
Cite this article
Kliger, A. Does daily haemodialysis reduce survival?. Nat Rev Nephrol 9, 8–9 (2013). https://doi.org/10.1038/nrneph.2012.247
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2012.247
This article is cited by
-
Dialysis frequency versus dialysis time, that is the question
Kidney International (2014)